AMA submission to the Therapeutic Goods Administration – Increased online access to ingredient information

In its submission, the AMA supports the TGA’s proposal to increase the amount of publicly available information on therapeutic good ingredients through the Australian Register of Therapeutic Goods (ARTG). This will benefit the safety and quality of therapeutic good use in Australia, and support transparency and consumer decision-making. This is especially important given the increase in the prevalence of allergies.